JYSZ2400055 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | License Renew | 2024-10-16 | | | | | view |
JYSZ2300038 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | License Renew | 2023-09-13 | | | | | view |
JYSZ1900056 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | License Renew | 2019-10-08 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2020-05-25 | view |
JYSZ1900055 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | License Renew | 2019-10-15 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2020-05-25 | view |
JYSF2000016 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2020-06-05 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2020-06-19 | view |
JYSB2400059 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2024-03-14 | | Novo Nordisk A/S | | | view |
JYSB2400035 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products(3.1) | Supplementary Application | 2024-02-27 | | Novo Nordisk A/S | | | view |
JYSB2400021 | 德谷胰岛素利拉鲁肽注射液 | Insulin Degludec;Liraglutide | Injection | Biological Products | Supplementary Application | 2024-02-01 | | | | | view |
JYSB2400017 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2024-01-30 | | | | | view |
JYSB2100076 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2021-03-20 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | In Review | 2021-03-19 | view |
JYSB2000417 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(1) | Supplementary Application | 2020-08-24 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2020-10-10 | view |
JYSB2000366 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(1) | Supplementary Application | 2020-08-07 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Filed | 2020-08-17 | view |
JYSB2000363 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(1) | Supplementary Application | 2020-08-06 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2020-10-10 | view |
JYSB2000362 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products(1) | Supplementary Application | 2020-08-06 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2020-10-10 | view |
JYSB2000290 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2020-06-25 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2020-09-23 | view |
JYSB1900059 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2019-02-27 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2019-03-13 | view |
JYSB1700220 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2017-12-15 | | Novo Nordisk A/S | Certificate Issued | 2018-04-16 | view |
JYSB1700197 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2017-11-17 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2017-12-21 | view |
JYSB1600073 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2016-05-10 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2017-01-12 | view |
JYSB1500199 | 利拉鲁肽注射液 | liraglutide | Injection | Biological Products | Supplementary Application | 2015-07-23 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2017-01-24 | view |